BioHarvest Sciences Inc. Announces Warrants Term Extension
Vancouver, British Columbia--(Newsfile Corp. - July 9, 2020) - BioHarvest Sciences Inc. (the "Company") (CSE: BHSC) announces that it has filed documentation with the Canadian Securities Exchange (the "Exchange") to amend the terms of an aggregate of 20,119,665 common share purchase warrants (the "Warrants") issued in September 27, 2018 pursuant to a non-brokered private placement. The warrants issued are exercisable into common shares in the capital of the Company at an exercise price of...
2020-07-09 11:54 AM EDT
BioHarvest Sciences Inc. Announces Closing of Private Placement and Granting and Cancellation of Stock Options
Vancouver, British Columbia--(Newsfile Corp. - June 10, 2020) - BioHarvest Sciences Inc. (CSE: BHSC) (the "Company") announced today that it has closed its 3,150,000 common shares private placement financing (the "Private Placement Financing") as disclosed in its news release dated June 3, 2020 by issuing 3,150,000 common shares at a price of $0.15 per share for gross proceeds of $472,500. The securities issued under the private placement will be subject to a hold period expiring four months...
2020-06-10 3:54 PM EDT
BioHarvest Sciences Inc. Appoints Eitan Popper as Chairman of the Advisory Board
Vancouver, British Columbia--(Newsfile Corp. - June 10, 2020) - BioHarvest Sciences Inc. (CSE: BHSC) (the "Company") BioHarvest Sciences Inc. (BHSC) is announcing today the appointment of Mr. Eitan Popper as the Chairman of the Company's Board of Advisors. Mr. Popper will assist the Company's senior management team with strategic matters, including but not limited to outlining the Company's Cannabis related strategy and the development of key strategic partnerships within the Cannabis...
2020-06-10 9:00 AM EDT
BioHarvest Sciences Inc. Appoints Ilan Sobel as New CEO
Vancouver, British Columbia--(Newsfile Corp. - June 9, 2020) - BioHarvest Sciences Inc. (CSE: BHSC) (the "Company") announces today the appointment of Mr. Ilan Sobel as the Chief Executive Officer replacing Dr. Zaki Rakib in this role. Dr. Rakib will assume the new positions of President and Chairman of the Board and as such Mr. Dave Ryan, previously President, will assume the role of Vice President of Investor Relations. The appointment of Mr. Sobel and the changes listed above are effective...
2020-06-09 12:55 PM EDT
BioHarvest Sciences Inc. Engages Hybrid Financial Ltd.
Vancouver, British Columbia--(Newsfile Corp. - May 28, 2020) - BioHarvest Sciences Inc. (CSE: BHSC) (the "Company") is pleased to announce that it has retained Hybrid Financial Ltd. ("Hybrid") to provide marketing services to the Company. Hybrid has been engaged to heighten market and brand awareness for BioHarvest Sciences Inc. and to broaden the Company's reach within the investment community. Hybrid has agreed to comply with all applicable securities laws and the policies of the Canadian...
2020-05-28 10:15 AM EDT
BioHarvest Sciences Inc. (formerly, Canna-V-Cell Sciences Inc.) Closes Agreement and Plan of Merger and announces the Results of its Annual General Meeting and Special Meeting
Vancouver, British Columbia--(Newsfile Corp. - April 21, 2020) - BioHarvest Sciences Inc. (CSE: BHSC) (the "Company") is pleased to announce that it has closed the Agreement and Plan of Merger dated December 9, 2019 (the "Merger Agreement") with BioHarvest Ltd. ("BioHarvest") and BioFarming Ltd as announced in the Company's news release dated January 13, 2020. The closing of the Merger Agreement completes the business combination of the Company and its controlling shareholder BioHarvest Ltd....
2020-04-21 4:31 PM EDT
Canna-V-Cell Announces Business Combination with its Controlling Shareholder BioHarvest Ltd. ("Bio Harvest")
Vancouver, British Columbia--(Newsfile Corp. - December 13, 2019) - Canna-V-Cell Sciences Inc. (CSE: CNVC) (the "Company") ("Canna V") announced today that it has entered into an Agreement and Plan of Merger dated December 9, 2019 with its 46% controlling shareholder BioHarvest Ltd. (BioHarvest) and the Company's wholly owned Israeli subsidiary Biofarming Ltd. Under the terms of the Agreement and Plan of Merger, Canna V will acquire 100% of BioHarvest by issuing 299,200,000 common shares at a...
2019-12-13 3:09 PM EST
CannaVcell Naturally Produces Cannabis' Active Ingredients Without Growing the Plant Itself
Vancouver, British Columbia--(Newsfile Corp. - September 30, 2019) - CannaVcell Sciences Inc. (CSE: CNVC) ("CannaVcell") announced last Thursdays, the first production of Cannabis cells in suspension, with a cannabinoid profile identical to that of the original cannabis plant - without the need to grown the plant itself. The achievement was possible using the breakthrough and patented BioHarvest's technology (CannaVcell is the worldwide exclusive licensee of the technology for cannabis...
2019-09-30 10:00 AM EDT
CannaVcell Announces Stable Production of Cannabis Cells, Trichomes, and Cannabinoids Without the Need to Grow the Cannabis Plant Itself
Vancouver, British Columbia--(Newsfile Corp. - September 26, 2019) - Using breakthrough proprietary and patented technology developed by BioHarvest Ltd, CannaVcell (CSE: CNVC) (the worldwide exclusive licensee of this technology for Cannabis applications) is announcing today the first ever production of Cannabis cells in suspension, with a cannabinoid profile identical to that of the source plant - without the need to grow the plant itself. This represents the successful completion of the...
2019-09-26 9:00 AM EDT
Canna-V-Cell Sciences Inc., Announces Significant Milestone
Vancouver, British Columbia--(Newsfile Corp. - August 26, 2019) - Canna-V-Cell Sciences Inc. (CSE: CNVC) ("CannaVcell") announces today it has reached a significant milestone of having Cannabis trichomes at the suspension phase. "This clearly confirms that the progress made to-date towards the completion of the 16 months development program has exceeded the expectations" said Dr. Yochi Hagay CTO of CannaVcell and added " we can now be a
2019-08-26 9:00 AM EDT
CORRECTION FROM SOURCE: Canna-V-Cell Sciences Inc. Announces Private Placement
Vancouver, British Columbia--(Newsfile Corp. - August 14, 2019) - Canna-V-Cell Sciences Inc. (CSE: CNVC) (the "Company") issued the following news release to amend its news release of August 13, 2019 to correct an error in the term of the warrants. The Company announces that the Company intends to complete a private placement of up to 6,666,667 units at a price $0.15 per unit for total proceeds of up to $1,000,000. Each unit will consist of one common share of the Company and one...
2019-08-14 8:30 AM EDT
Canna-V-Cell Sciences Inc. Announces Private Placement
Vancouver, British Columbia--(Newsfile Corp. - August 13, 2019) - Canna-V-Cell Sciences Inc. (CSE: CNVC) (the "Company") announces that the Company intends to complete a private placement of up to 6,666,667 units at a price $0.15 per unit for total proceeds of up to $1,000,000. Each unit will consist of one common share of the Company and one non-transferable share purchase warrant. Each warrant will be exercisable to purchase an additional common share at a price of $.30 per share for a...
2019-08-13 8:11 PM EDT
Canna-V-Cell Sciences Inc. July 9th, 2019: Shareholders Letter
Vancouver, British Columbia--(Newsfile Corp. - July 9, 2019) - I am happy to have this opportunity to write my first opened letter addressed to you, the shareholders of Canna-V-Cell (CSE: CNVC). As you all know, we started our journey in October of last year with the major task of adapting the breakthrough proprietary and patented biofarming technology to Cannabis. Biofarming enables the production of all the active ingredients without growing the plant itself. So far, we have been following...
2019-07-09 10:57 AM EDT
CannaVcell enhances its IR activities by hiring INN and Flinnwest services
Vancouver, British Columbia--(Newsfile Corp. - June 25, 2019) - Canna-V-Cell Sciences Inc. (CSE: CNVC) ("CannaVcell") With the increase in its confidence of achieving the goals of the Cannabis biofarming development program, CannaVcell is hiring both Flinnwest and INN services. "This increase in confidence requires a further enhancement in the communication with the investment community" said Dr. Zaki Rakib the CEO while adding "as we are getting closer to demonstrate the feasibility and...
2019-06-25 9:00 AM EDT
Canna-V-Cell Increases Confidence in Its Biofarming Technology by Growing Cannabis Trichomes Containing Active Cannabinoids at the Callus Level
Vancouver, British Columbia--(Newsfile Corp. - May 28, 2019) - Canna-V-Cell Sciences Inc. (CSE: CNVC) (The "Company"), Canna-V-Cell is announcing today that as part of its program of applying the biofarming technology to Cannabis, it has achieved the critical milestone of ensuring the existence of active cannabinoids ingredients in its bank of cells required for the next step in the biofarming process. Active cannabinoids exist in the trichomes of the Cannabis plant. Trichomes, especially the...
2019-05-28 9:00 AM EDT
Canna-V-Cell Sciences Inc. announces Israel health ministry approval
Vancouver, British Columbia--(Newsfile Corp. - November 19, 2018) - Canna-V-Cell Sciences Inc. (CSE: CNVC) (the "CannaVcell") CannaVcell, in its aim to develop and produce Cannabis active ingredients on the basis of the biofarming technology, is announcing that it has received through its subsidiary in Israel, the authorization of the health ministry of Israel to conduct research and development with Cannabis plants. "This is a major milestone in the adaptation of the cell growth technology...
2018-11-19 8:30 AM EST